<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8"/>
  <meta name="viewport" content="width=device-width,initial-scale=1.0"/>
  <title>CMC Wise – Wireframe Kit</title>
  <link rel="stylesheet" href="style.css"/>
</head>
<body>

<header class="navbar">
  <div class="brand">
    <div class="logo-box">
      LOGO
    </div>
    <div>CMC Wise</div>
  </div>
  <nav>
    <ul>
      <li>Home</li>
      <li>R&amp;D</li>
      <li>Regulatory</li>
      <li>About</li>
      <li>Insights</li>
      <li>Contact</li>
      <li><div class="cta-button">Let's Talk</div></li>
    </ul>
  </nav>
</header>

<div class="page" id="home">
  <section class="section">
    <div class="wrap grid-2">
      <div>
        <h1>CMC Wise – Small Molecule R&D and Regulatory Services</h1>
        <p>Short positioning statement goes here. Max ~2 lines. Explains that CMC Wise unites small-molecule formulation R&amp;D and multi-region regulatory strategy (EMA / MHRA / FDA) into one integrated platform.</p>
        <div style="display:flex;flex-wrap:wrap;gap:16px;">
          <div class="cta-button cta-dark">Explore R&amp;D</div>
          <div class="cta-button cta-mid">Regulatory Affairs</div>
        </div>
      </div>
      <div>
        <div class="placeholder-block hero-placeholder">
          HERO VISUAL / MOLECULE ANIMATION / PARTICLE GRAPHIC
        </div>
      </div>
    </div>
  </section>

  <section class="section alt">
    <div class="wrap center-text">
      <h2>Who We Are</h2>
      <p>CMC Wise is a UK-based pharma R&amp;D and regulatory platform focused on small molecules. This block mirrors the “about us” tone. It should be concise and confident. Max ~120 words.</p>
    </div>
  </section>

  <section class="section">
    <div class="wrap grid-2">
      <div class="card">
        <h3>R&amp;D</h3>
        <p>Formulation innovation for sterile injectables, ophthalmics, oral solids, and oral liquids. Data-driven design. CMC-aligned output. Button leads to full R&amp;D page.</p>
        <div class="cta-button cta-dark small-cta">Explore R&amp;D →</div>
      </div>
      <div class="card">
        <h3>Regulatory Affairs</h3>
        <p>EMA / MHRA / FDA submissions, lifecycle management, labeling, 505(b)(2) planning. Button leads to Regulatory page.</p>
        <div class="cta-button cta-mid small-cta">Explore Regulatory →</div>
      </div>
    </div>
  </section>

  <section class="section alt">
    <div class="wrap">
      <h2>Our Difference</h2>
      <div class="grid-4">
        <div class="card">
          <div class="placeholder-block icon-placeholder">ICON</div>
          <h3 class="h3-small">Science-Driven</h3>
          <p>We design around the molecule and the data, not around a generic template.</p>
        </div>
        <div class="card">
          <div class="placeholder-block icon-placeholder">ICON</div>
          <h3 class="h3-small">Integrated Workflow</h3>
          <p>Formulation and regulatory speak to each other from day zero.</p>
        </div>
        <div class="card">
          <div class="placeholder-block icon-placeholder">Senior-Led ICON</div>
          <h3 class="h3-small">Senior-Led</h3>
          <p>Access to decision-makers, not layers of account management.</p>
        </div>
        <div class="card">
          <div class="placeholder-block icon-placeholder">ICON</div>
          <h3 class="h3-small">Transparent Milestones</h3>
          <p>Defined steps, documented data, audit-friendly output.</p>
        </div>
      </div>
    </div>
  </section>

  <section class="section">
    <div class="wrap">
      <h2>Insights</h2>
      <div class="grid-3">
        <div class="card">
          <div class="placeholder-block article-thumb">ARTICLE THUMBNAIL</div>
          <h3 class="h3-small">Designing Stability Studies for 505(b)(2)</h3>
          <p class="desc">Short abstract excerpt (2–3 lines).</p>
          <div class="read-link">Read →</div>
        </div>
        <div class="card">
          <div class="placeholder-block article-thumb">ARTICLE THUMBNAIL</div>
          <h3 class="h3-small">Bridging EMA &amp; MHRA Post-Brexit</h3>
          <p class="desc">Short abstract excerpt (2–3 lines).</p>
          <div class="read-link">Read →</div>
        </div>
        <div class="card">
          <div class="placeholder-block article-thumb">ARTICLE THUMBNAIL</div>
          <h3 class="h3-small">Why Bioinformatics Belongs in Formulation</h3>
          <p class="desc">Short abstract excerpt (2–3 lines).</p>
          <div class="read-link">Read →</div>
        </div>
      </div>
    </div>
  </section>
</div>

<div class="page" id="rnd">
  <section class="section">
    <div class="wrap grid-2">
      <div>
        <h1>Formulation Science, Reimagined for Small Molecules.</h1>
        <p>Hero copy: every molecule behaves differently. We build data-driven formulations tuned to your molecule and CMC timeline. Button scrolls to philosophy.</p>
        <div class="cta-button cta-dark small-cta">Our Philosophy ↓</div>
      </div>
      <div>
        <div class="placeholder-block hero-placeholder">
          R&amp;D HERO VISUAL  
          (vials / particle dispersion / long-acting depot)
        </div>
      </div>
    </div>
  </section>

  <section class="section alt">
    <div class="wrap grid-2">
      <div>
        <h2>Science that adapts to the molecule.</h2>
        <p>We start with solubility, ionization, degradation, polymorph behavior. We model risks before we run them. We design before we test, predict before we scale.</p>
      </div>
      <div>
        <div class="placeholder-block mid-placeholder">
          SIMPLE ANIMATION / GRAPHIC  
          "MOLECULE → FORMULATION"
        </div>
      </div>
    </div>
  </section>

  <section class="section">
    <div class="wrap">
      <h2>Where chemistry meets data and manufacturing reality.</h2>
      <div class="grid-4">
        <div class="card">
          <h3>Pharmaceutics</h3>
          <p>Translate molecular properties into dosage form behavior.</p>
        </div>
        <div class="card">
          <h3>Analytical Chemistry</h3>
          <p>Define purity, potency, and stability with validated methods.</p>
        </div>
        <div class="card">
          <h3>Bioinformatics / Biostats</h3>
          <p>Predict excipient compatibility and release kinetics via DoE.</p>
        </div>
        <div class="card">
          <h3>Regulatory Science</h3>
          <p>Build Module 3-ready data packages in parallel with lab work.</p>
        </div>
      </div>
    </div>
  </section>

  <section class="section alt">
    <div class="wrap">
      <h2>Formulating for Function.</h2>
      <div class="grid-4">
        <div class="card">
          <div class="placeholder-block mid-placeholder">STERILE INJECTABLE IMAGE</div>
          <h3>Sterile Injectables</h3>
          <p>Depot, RTU, nanosuspensions, emulsions. Focus on particle size, rheology, solvent balance.</p>
        </div>
        <div class="card">
          <div class="placeholder-block mid-placeholder">OPHTHALMIC IMAGE</div>
          <h3>Ophthalmic</h3>
          <p>Aqueous &amp; suspension systems. Viscosity, preservative balance, sterility built in early.</p>
        </div>
        <div class="card">
          <div class="placeholder-block mid-placeholder">TABLETS / PELLETS IMAGE</div>
          <h3>Oral Solids</h3>
          <p>IR / MR tablets, MUPS, pellets. Low-solubility actives, polymorph control, release matrices.</p>
        </div>
        <div class="card">
          <div class="placeholder-block mid-placeholder">LIQUID / SUSPENSION IMAGE</div>
          <h3>Oral Liquids</h3>
          <p>Palatable solutions &amp; suspensions. Taste masking, dose uniformity, patient usability.</p>
        </div>
      </div>
    </div>
  </section>

  <section class="section">
    <div class="wrap">
      <h2>Agile development. Transparent milestones.</h2>
      <p>Fee-for-service (you own the data) and co-development (shared risk / shared upside). Both run on milestone-driven execution and audit-ready documentation.</p>
      <div class="timeline-row">
        <div class="timeline-step">
          <strong>1. Pre-formulation</strong><br/>
          Solubility, salt/polymorph screening, risk map.
        </div>
        <div class="timeline-step">
          <strong>2. Formulation Design</strong><br/>
          DoE, excipient matrix, prototype build.
        </div>
        <div class="timeline-step">
          <strong>3. Analytics &amp; Stability</strong><br/>
          Method validation, ICH stability, release profile.
        </div>
        <div class="timeline-step">
          <strong>4. Scale-Up &amp; Transfer</strong><br/>
          Exhibit batch, tech transfer, CMC package.
        </div>
      </div>
    </div>
  </section>

  <section class="section alt">
    <div class="wrap">
      <h2>Tools that turn data into design.</h2>
      <table class="cap-table">
        <tr>
          <th>Capability</th>
          <th>Focus</th>
        </tr>
        <tr>
          <td>Pre-Formulation</td>
          <td>Solubility &amp; pKa profiling, polymorph screening, degradation kinetics</td>
        </tr>
        <tr>
          <td>Formulation Design</td>
          <td>QbD DoE, excipient compatibility, stability prediction</td>
        </tr>
        <tr>
          <td>Analytical Sciences</td>
          <td>HPLC/GC/LC-MS method development &amp; validation</td>
        </tr>
        <tr>
          <td>Stability Programs</td>
          <td>ICH-compliant accelerated / photostability studies</td>
        </tr>
        <tr>
          <td>Scale-Up</td>
          <td>Process optimization, aseptic fill simulation, exhibit batch</td>
        </tr>
        <tr>
          <td>Documentation</td>
          <td>CMC data packages, tech transfer reports, audit trail</td>
        </tr>
      </table>
    </div>
  </section>

  <section class="section">
    <div class="wrap grid-2">
      <div>
        <h2>We build formulations that endure — scientifically and regulatorily.</h2>
        <p>“We don’t just develop formulations. We build the data packages that make them real.”</p>
      </div>
      <div class="card align-start">
        <h3>Start a Discussion</h3>
        <p>Short confidentiality reassurance. Invite them to share target molecule, dosage form, timeline pressure.</p>
        <div class="cta-button cta-dark small-cta">Contact Us →</div>
      </div>
    </div>
  </section>
</div>

<div class="page" id="regulatory">
  <section class="section">
    <div class="wrap grid-2">
      <div>
        <h1>Global Strategy. Local Compliance. Submission-Ready Execution.</h1>
        <p>We align science, CMC data, and submission logic across EMA, MHRA, and FDA. Hero block leads into “Our Approach.”</p>
        <div class="cta-button cta-mid small-cta">Our Approach ↓</div>
      </div>
      <div>
        <div class="placeholder-block hero-placeholder">
          REGULATORY HERO VISUAL  
          (CTD Modules / submission timeline motif)
        </div>
      </div>
    </div>
  </section>

  <section class="section alt">
    <div class="wrap grid-2">
      <div>
        <h2>Regulation as a continuum of science.</h2>
        <p>We build the submission story while the science is still being generated, ensuring every number in the dossier is anchored and defensible.</p>
      </div>
      <div>
        <div class="placeholder-block mid-placeholder">
          VENN / OVERLAP DIAGRAM  
          SCIENCE ∩ QUALITY ∩ COMPLIANCE
        </div>
      </div>
    </div>
  </section>

  <section class="section">
    <div class="wrap">
      <h2>Cross-agency expertise.</h2>
      <div class="grid-3">
        <div class="card">
          <h3>EMA</h3>
          <p>CP, DCP, MRP, NP. Scientific Advice. Module 1–5 authoring. Variations &amp; renewals across member states.</p>
        </div>
        <div class="card">
          <h3>MHRA (UK)</h3>
          <p>National procedure, Reliance pathway, accelerated / rolling review. Ongoing lifecycle management, PSURs, variations.</p>
        </div>
        <div class="card">
          <h3>FDA (US)</h3>
          <p>505(b)(1), 505(b)(2), ANDA. Meeting briefing books, IND/NDA assembly, ESG submission. IR / DRL / CRL responses, SPL &amp; labeling.</p>
        </div>
      </div>
    </div>
  </section>

  <section class="section alt">
    <div class="wrap grid-2">
      <div>
        <h2>Every module tells a story.</h2>
        <p>We maintain traceability from analytical tables to clinical summaries. Clear logic, consistent data, regulator confidence.</p>
      </div>
      <div>
        <div class="placeholder-block mid-placeholder">
          STACK OF "MODULE 1 / 2 / 3 / 4 / 5"  
          ICONS / DOCUMENT PILE
        </div>
      </div>
    </div>
  </section>

  <section class="section">
    <div class="wrap grid-2">
      <div>
        <h2>Compliance beyond approval.</h2>
        <p>We manage variations, renewals, labeling updates, PSURs. Change control systems that scale across regions.</p>
        <div class="placeholder-block small-placeholder">
          POST-APPROVAL TIMELINE / ARROWS
        </div>
      </div>
      <div>
        <h2>Pathway strategy with foresight.</h2>
        <p>505(b)(2), hybrid, national vs centralized — we model pathway, cost, and data expectations before you commit budget.</p>
        <div class="placeholder-block small-placeholder">
          DECISION TREE GRAPHIC  
          "IF data set A → ROUTE X"
        </div>
      </div>
    </div>
  </section>

  <section class="section alt">
    <div class="wrap grid-2">
      <div>
        <h2>From lab bench to Module 3.</h2>
        <p>Regulatory and R&amp;D share the same spine here. The formulation rationale, stability story, and manufacturing narrative are built to be dossier-ready.</p>
        <div class="cta-button cta-mid small-cta">See R&amp;D Integration →</div>
      </div>
      <div>
        <div class="placeholder-block mid-placeholder">
          LAB TEAM / HANDOVER VISUAL  
          (R&amp;D ↔ Regulatory)
        </div>
      </div>
    </div>
  </section>

  <section class="section">
    <div class="wrap grid-2">
      <div>
        <h2>Agile expertise. Global perspective.</h2>
        <p>Direct access to senior people. Transparent scopes. No big-consultancy fog.</p>
      </div>
      <div class="card align-start">
        <h3>Plan Your Next Submission</h3>
        <p>Short text reaffirming trust / confidentiality. Invite MHRA / EMA / FDA discussions.</p>
        <div class="cta-button cta-mid small-cta">Contact Us →</div>
      </div>
    </div>
  </section>
</div>

<div class="page" id="about">
  <section class="section">
    <div class="wrap">
      <h1>Science, Compliance, and Clarity — That’s Our DNA.</h1>
      <p>Mission / origin story. “Founded to close the gap between smart formulation science and regulatory reality.” ~80-120 words.</p>
    </div>
  </section>

  <section class="section alt">
    <div class="wrap">
      <h2>Leadership &amp; Scientific Advisors</h2>
      <div class="grid-4">
        <div class="card center-text">
          <div class="placeholder-block headshot">HEADSHOT</div>
          <h3 class="h3-small">Name Here</h3>
          <p class="small-text">Short bio (2–3 lines). Area of focus / experience / credibility marker.</p>
        </div>
        <div class="card center-text">
          <div class="placeholder-block headshot">HEADSHOT</div>
          <h3 class="h3-small">Name Here</h3>
          <p class="small-text">Short bio (2–3 lines). Area of focus / experience / credibility marker.</p>
        </div>
        <div class="card center-text">
          <div class="placeholder-block headshot">HEADSHOT</div>
          <h3 class="h3-small">Name Here</h3>
          <p class="small-text">Short bio (2–3 lines). Area of focus / experience / credibility marker.</p>
        </div>
        <div class="card center-text">
          <div class="placeholder-block headshot">HEADSHOT</div>
          <h3 class="h3-small">Name Here</h3>
          <p class="small-text">Short bio (2–3 lines). Area of focus / experience / credibility marker.</p>
        </div>
      </div>
    </div>
  </section>

  <section class="section">
    <div class="wrap grid-4">
      <div class="card">
        <h3>Integrity</h3>
        <p>No theatre. Just honest data and clear narrative.</p>
      </div>
      <div class="card">
        <h3>Precision</h3>
        <p>Our work stands in audits and agency review.</p>
      </div>
      <div class="card">
        <h3>Collaboration</h3>
        <p>We act like part of your internal team, not an external supplier.</p>
      </div>
      <div class="card">
        <h3>Agility</h3>
        <p>Senior decision-making without corporate delay.</p>
      </div>
    </div>
  </section>

  <section class="section alt">
    <div class="wrap grid-2">
      <div>
        <h2>Global Network</h2>
        <p>CRO / CDMO partners, EU / UK / US regulatory reach, and manufacturing transfer capability. ~60-80 words.</p>
      </div>
      <div>
        <div class="placeholder-block mid-placeholder">
          MAP / NODE GRAPH  
          LONDON AS HUB → EU / US / ASIA
        </div>
      </div>
    </div>
  </section>
</div>

<div class="page" id="insights">
  <section class="section">
    <div class="wrap">
      <h1>Insights</h1>
      <p>Short intro. “Perspectives on formulation design, regulatory strategy, and lifecycle thinking.”</p>
    </div>
  </section>

  <section class="section alt">
    <div class="wrap filter-bar">
      <div class="filter-text">Filters: All • Formulation • Regulatory • 505(b)(2) • CMC</div>
      <div class="placeholder-block search-placeholder">
        SEARCH INPUT (future)
      </div>
    </div>
  </section>

  <section class="section">
    <div class="wrap grid-3">
      <div class="card">
        <div class="placeholder-block article-thumb">THUMBNAIL</div>
        <div class="tag">Regulatory Pathways</div>
        <h3 class="h3-small">Bridging EMA and MHRA Submissions</h3>
        <p class="small-text">Excerpt preview 2–3 lines. Talks about post-Brexit alignment strategy without duplication of effort.</p>
        <div class="read-link">Read →</div>
      </div>
      <div class="card">
        <div class="placeholder-block article-thumb">THUMBNAIL</div>
        <div class="tag">CMC / Stability</div>
        <h3 class="h3-small">Designing Stability Studies for 505(b)(2)</h3>
        <p class="small-text">Excerpt preview 2–3 lines. Focus on long-acting injectables and depot systems.</p>
        <div class="read-link">Read →</div>
      </div>
      <div class="card">
        <div class="placeholder-block article-thumb">THUMBNAIL</div>
        <div class="tag">Formulation Design</div>
        <h3 class="h3-small">Why Bioinformatics Belongs in Formulation</h3>
        <p class="small-text">Excerpt preview 2–3 lines. Predictive tools, excipient compatibility, release modeling.</p>
        <div class="read-link">Read →</div>
      </div>
    </div>
  </section>
</div>

<div class="page" id="contact">
  <section class="section">
    <div class="wrap grid-2">
      <div>
        <h1>Let’s Talk.</h1>
        <p>“Ready to discuss your next molecule or submission? We work with companies building small-molecule assets across sterile injectables, ophthalmics, oral solids, and oral liquids — and we support submissions across EMA, MHRA, and FDA.”</p>
        <p class="contact-details">
          CMC Wise Ltd<br/>
          63-66 Hatton Garden, Fifth Floor, Suite 23<br/>
          London EC1N 8LE, United Kingdom<br/>
          info@cmcwise.com
        </p>
      </div>
      <div>
        <div class="card">
          <h2>Send a Message</h2>
          <div class="placeholder-block form-field">NAME FIELD</div>
          <div class="placeholder-block form-field">COMPANY FIELD</div>
          <div class="placeholder-block form-field">EMAIL FIELD</div>
          <div class="placeholder-block form-textarea">MESSAGE TEXTAREA</div>
          <div class="placeholder-block form-checkbox">[ ] Please send NDA first</div>
          <div class="cta-button cta-dark full-width">Submit →</div>
        </div>
      </div>
    </div>
  </section>

  <section class="section alt">
    <div class="wrap">
      <div class="placeholder-block hero-placeholder">
        EMBED MAP OF LONDON OFFICE / STATIC MAP IMAGE
      </div>
    </div>
  </section>
</div>

<footer class="site-footer">
  <div class="footer-grid">
    <div>
      <h4>CMC Wise</h4>
      <p>Formulation R&amp;D and Regulatory Affairs for small-molecule pharmaceuticals.</p>
      <p>UK-based. Globally connected.</p>
    </div>

    <div>
      <h4>Navigation</h4>
      <ul>
        <li>Home</li>
        <li>R&amp;D</li>
        <li>Regulatory</li>
        <li>About</li>
        <li>Insights</li>
        <li>Contact</li>
      </ul>
    </div>

    <div>
      <h4>Contact</h4>
      <p>CMC Wise Ltd</p>
      <p>63-66 Hatton Garden, Fifth Floor, Suite 23</p>
      <p>London EC1N 8LE, United Kingdom</p>
      <p>info@cmcwise.com</p>
    </div>

    <div>
      <h4>Legal</h4>
      <ul>
        <li>Privacy Notice</li>
        <li>Terms</li>
      </ul>
    </div>

    <div class="copyright">
      © CMC Wise. All rights reserved.
    </div>
  </div>
</footer>

</body>
</html>
